IGC Pharma, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: IGC Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
IGC Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.76M, a 29.3% increase year-over-year.
IGC Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$9.32M, a 14.5% increase year-over-year.
IGC Pharma, Inc. annual Operating Income (Loss) for 2023 was -$9.8M, a 15.3% increase from 2022.
IGC Pharma, Inc. annual Operating Income (Loss) for 2022 was -$11.6M, a 25% increase from 2021.
IGC Pharma, Inc. annual Operating Income (Loss) for 2021 was -$15.4M, a 76.8% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$9.32M	-$1.76M	+$731K	+29.3%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	-$10.1M	-$2.4M	-$257K	-12%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	-$9.8M	-$2.17M	+$1.83M	+45.8%	Jan 1, 2024	Mar 31, 2024	10-K	2024-06-24
Q4 2023	-$11.6M	-$3M	-$720K	-31.6%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-14
Q3 2023	-$10.9M	-$2.49M	-$3K	-0.12%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	-$10.9M	-$2.14M	+$663K	+23.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	-$11.6M	-$4M	+$2.5M	+38.4%	Jan 1, 2023	Mar 31, 2023	10-K	2024-06-24
Q4 2022	-$14.1M	-$2.28M	+$107K	+4.49%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-14
Q3 2022	-$14.2M	-$2.49M	+$1.86M	+42.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$16M	-$2.8M	-$608K	-27.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$15.4M	-$6.5M	-$3.71M	-133%	Jan 1, 2022	Mar 31, 2022	10-K	2023-07-07
Q4 2021	-$11.7M	-$2.39M	-$59K	-2.54%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-02-14
Q3 2021	-$11.7M	-$4.35M	-$2.67M	-159%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-01
Q2 2021	-$8.99M	-$2.19M	-$263K	-13.6%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-05
Q1 2021	-$8.72M	-$2.79M	-$348K	-14.2%	Jan 1, 2021	Mar 31, 2021	10-K	2022-06-23
Q4 2020	-$8.38M	-$2.33M	-$648K	-38.6%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-10
Q3 2020	-$7.73M	-$1.68M	-$388K	-30.1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-29
Q2 2020	-$7.34M	-$1.93M	-$476K	-32.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11
Q1 2020	-$6.86M	-$2.44M	-$744K	-43.8%	Jan 1, 2020	Mar 31, 2020	10-K	2021-06-14
Q4 2019	-$6.12M	-$1.68M	-$100K	-6.34%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-02-16
Q3 2019	-$6.02M	-$1.29M	-$433K	-50.6%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-20
Q2 2019	-$5.59M	-$1.46M	-$944K	-185%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-19
Q1 2019	-$4.64M	-$1.7M	-$1.04M	-159%	Jan 1, 2019	Mar 31, 2019	10-K	2020-07-13
Q4 2018	-$3.6M	-$1.58M	-$1.11M	-234%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-02-10
Q3 2018	-$2.5M	-$855K	-$592K	-225%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-06
Q2 2018	-$1.9M	-$511K	-$115K	-29%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-09
Q1 2018	-$1.79M	-$657K	+$143K	+17.9%	Jan 1, 2018	Mar 31, 2018	10-K	2019-06-14
Q4 2017	-$1.93M	-$473K	-$86.9K	-22.5%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-12
Q3 2017	-$1.85M	-$263K	+$287K	+52.2%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-16
Q2 2017	-$2.13M	-$396K	-$77.5K	-24.3%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-03
Q1 2017	-$2.05M	-$800K	+$965K	+54.7%	Jan 1, 2017	Mar 31, 2017	10-K	2018-06-21
Q4 2016	-$3.02M	-$386K	-$11.1K	-2.96%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-02-20
Q3 2016	-$3.01M	-$550K	-$41.4K	-8.15%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-17
Q2 2016	-$2.97M	-$319K	-$61.5K	-23.9%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-18
Q1 2016	-$2.91M	-$1.77M	+$163K	+8.44%	Jan 1, 2016	Mar 31, 2016	10-K	2017-07-14
Q4 2015	-$3.07M	-$375K	+$124K	+24.9%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-21
Q3 2015	-$3.19M	-$508K	+$257K	+33.6%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-21
Q2 2015	-$3.45M	-$257K	+$893K	+77.6%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-16
Q1 2015	-$4.34M	-$1.93M	-$388K	-25.2%	Jan 1, 2015	Mar 31, 2015	10-K	2016-07-14
Q4 2014	-$3.95M	-$499K	-$205K	-69.8%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-16
Q3 2014	-$3.75M	-$765K	-$333K	-76.9%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-13
Q2 2014	-$3.42M	-$1.15M	-$889K	-341%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-14
Q1 2014	-$2.53M	-$1.54M	+$861K	+35.9%	Jan 1, 2014	Mar 31, 2014	10-K	2015-07-14
Q4 2013	-$3.39M	-$294K	-$749K	-165%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-02-12
Q3 2013	-$2.64M	-$433K	-$88.9K	-25.9%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-13
Q2 2013	-$2.55M	-$261K	-$66.6K	-34.3%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-14
Q1 2013	-$2.48M	-$2.4M	+$2.64M	+52.4%	Jan 1, 2013	Mar 31, 2013	10-K	2014-07-15
Q4 2012	-$5.13M	$455K	+$1.5M		Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-14
Q3 2012	-$6.63M	-$344K	+$376K	+52.2%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-08
Q2 2012	-$7.01M	-$194K	+$504K	+72.2%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-16
Q1 2012	-$7.51M	-$5.04M	+$8.02M	+61.4%	Jan 1, 2012	Mar 31, 2012	10-K/A	2014-07-15
Q4 2011	-$15.5M	-$1.05M	+$441K	+29.6%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-13
Q3 2011	-$16M	-$719K	+$76.4K	+9.6%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-14
Q2 2011	-$16.1M	-$698K	-$166K	-31.2%	Apr 1, 2011	Jun 30, 2011	10-Q/A	2012-08-21
Q1 2011	-$15.9M	-$13.1M			Jan 1, 2011	Mar 31, 2011	10-K	2012-07-16
Q4 2010		-$1.49M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-16
Q3 2010		-$796K			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-18
Q2 2010		-$532K			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.